How one California-based CCO is responding to coronavirus risk
We recently spoke with the compliance chief for California-based biopharmaceutical Aimmune, Fabiana Lacerca-Allen, about her role in helping her company proactively plan for and respond to the risks posed by COVID-19.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
ArticleCoronavirus will raise profile of compliance moving forward
The status of compliance practitioners has grown over the past decade, buoyed by changes in the regulatory space as well as record penalties for transgressions. It will become even more important in the wake of the coronavirus pandemic.
-
ArticleU.S. sees steep drop in penalties in 2025, while fines elsewhere increase
Firms worldwide got a break in 2025 on penalties for anti-money laundering (AML) failures, a new report has found.
-
News BriefFTC puts GM’s puts connected vehicle data practices under compliance spotlight
The U.S. Federal Trade Commission finalized its order against General Motors and its OnStar subsidiary over the improper usage of geolocation and driving behavior data of drivers.
More from Risk Management
-
ArticleCompliance must prepare for post-quantum cryptography requirements in contracts
While companies focus on the risks, opportunities, and regulations emerging around AI, the next tech challenge is already on the horizon. Quantum computers are here – and so are the associated crime risks, plus some encryption protections.
-
ArticleRapid regulatory change requires investment in compliance processes in financial services firms
Geopolitical instability and a general focus on increasing growth and productivity by governments worldwide are causing a slew of regulatory changes in the financial services sector. But most firms are failing to identify potential compliance changes early enough to make meaningful decisions.
-
ArticleCompliance should protect firms from AI-washing investigations and insurance claims
Insurance firms are warning that AI-washing could trigger a slew of cases against directors, and are adjusting their directors’ and officers’ liability premiums accordingly. With regulators cracking down on AI-washing, compliance could be a crucial line of defense and save companies on their insurance costs.